Skip to main content
Equibles

CITADEL ADVISORS LLC

Position in ANIP — Ani Pharmaceuticals Inc

CIK 1423053 MIAMI, FL
Back to ANIP Full portfolio

Position in ANIP

as of Jun 30, 2026 · filed Sep 2, 2026
Position Value
$7,953,667
-$896,138 QoQ
Shares Held
96,082
-16.5% QoQ
Ownership
0.418%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#59
of 305 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ANIP Over Time

Shares Held

Position Value (USD)

Derivatives in ANIP

reported options exposure · as of Jun 30, 2026
CallValue
$215,228
CallShares
2,600
PutValue
$504,958
PutShares
6,100

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

CITADEL ADVISORS LLC holds $1,255,675,844 across 65 Drug Manufacturers - Specialty & Generic names. ANIP ranks #15 (0.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ELAN
Elanco Animal Health Inc
 9,668,611 $237,944,516
2 ZTS
Zoetis Inc.
 3,188,263 $229,108,578
3 UTHR
UNITED THERAPEUTICS Corp
 304,692 $165,091,266
4 LNTH
Lantheus Holdings, Inc.
 1,376,480 $152,706,691
5 INDV
Indivior Pharmaceuticals, Inc.
 2,667,827 $109,460,941
6 ALKS
Alkermes plc.
 1,645,101 $86,203,291
7 SUPN
Supernus Pharmaceuticals, Inc.
 1,373,982 $63,903,902
8 HIMS
Hims & Hers Health, Inc.
 846,936 $29,363,271

All Filings in ANIP

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $504,958 6,100
2026-06-30 $7,953,667 96,082
2026-06-30 $215,228 2,600
2026-03-31 $515,230 6,700
2026-03-31 $8,849,805 115,082
2025-12-31 $631,520 8,000
2025-12-31 $371,018 4,700
2025-12-31 $1,611,560 20,415
2025-09-30 $53,135,785 580,085
2025-09-30 $540,440 5,900
2025-09-30 $641,200 7,000
2025-06-30 $495,900 7,600
2025-06-30 $37,168,357 569,630
2025-03-31 $48,426,876 723,329
2025-03-31 $575,770 8,600
2025-03-31 $133,900 2,000
2024-12-31 $187,952 3,400
2024-12-31 $32,703,315 591,594
2024-12-31 $597,024 10,800
2024-09-30 $417,620 7,000
2024-09-30 $31,612,461 529,877
2024-09-30 $698,022 11,700
2024-06-30 $23,455,826 368,339
2024-06-30 $789,632 12,400
2024-06-30 $490,336 7,700
2024-03-31 $8,210,292 118,766
2024-03-31 $725,865 10,500
2024-03-31 $739,691 10,700
2023-12-31 $705,792 12,800
2023-12-31 $9,594,139 173,996
2023-12-31 $242,616 4,400
2023-09-30 $278,688 4,800
2023-09-30 $592,212 10,200
2023-09-30 $2,835,069 48,830
2023-06-30 $2,491,413 46,283
2023-06-30 $506,002 9,400
2023-06-30 $220,703 4,100
2023-03-31 $230,376 5,800
2023-03-31 $333,648 8,400
2023-03-31 $14,616 368
2022-12-31 $12,994 323
2022-12-31 $108,621 2,700
2022-12-31 $124,713 3,100
2022-09-30 $284,470 8,851
2022-06-30 $231,426 7,800
2022-06-30 $2,142,648 72,216
2022-03-31 $354,186 12,600
2022-03-31 $224,542 7,988
2021-12-31 $410,112 8,900
2021-12-31 $820,224 17,800